iMIND Publications, Presentations, and Scientific Sessions
Publications:
Assocation of OCTA parameters with Age in Cognitively Healthy Older Adults
Choroidal Vascularity Index: A Step Towards Software as a Medical Device
Correlation of OCTA and Volumetric MRI in Mild Cognitive Impairment and Alzheimer's Disease
Is OCT Angiography Useful in Neurodegenerative Diseases?
Repeatability of Peripapillary Optical Coherence Tomography Angiography Parameters in Older Adults
Structural and Functional Retinal Changes in Preclinical Alzheimer Disease
Characterization of Retinal Microvascular and Choroidal Structural Changes in Parkinson Disease
Assessing the Retinal Microvasculature in Individuals With Early and Late-Onset Alzheimer's Disease
Retinal and Choroidal Changes in Men Compared with Women with Alzheimer’s Disease
Repeatability of Peripapillary OCT Angiography in Neurodegenerative Disease
Standardization in Ophthalmic Imaging
Presentations and Scientific Sessions:
Presentation to US Senate Special Committee on Aging - April 2, 2019
Polascik BW, Yoon S, Grewal DS, Hoffmeyer GC, Fekrat S. Assessment of differences in retinal microvasculature using optical coherence tomography angiography in Alzheimer’s disease: a twin discordance report. North Carolina Society of Eye Physicians and Surgeons Annual Meeting, Hot Springs, Virginia.
Yoon SP, Grewal DS, Polascik BW, Burke JP, Fekrat S. Comparison of retinal microvasculature and neurodegenerative changes among Alzheimer’s Disease, Mild Cognitive Impairment, and Controls. ARVO 2018, Hawaii.
Grewal DS, Yoon SP, Polascik BW, Thompson AC, Burke J, Dunn C, Johnson K, Fekrat S. Retinal microvasculature and neurodegenerative changes among Alzheimer’s disease, mild cognitive impairment, and controls. AAO 2018, Chicago.
Polascik BW, Thompson AC, Yoon SP, Burke J, Grewal DS, Fekrat S. Association of OCT angiography parameters with age in normal older adults. AAO 2018, Chicago.
Wisely CE, Wang D, Henao R, Grewal DS, Yoon SP, Polascik BW, Thompson AC, Burke JR, Carin L, Fekrat S. Deep learning algorithm for diagnosis of Alzheimer’s disease using multimodal retinal imaging. ARVO 2019, Vancouver
Bhullar P, Pead E, Thompson AC, Yoon SP, Grewal DS, Polascik BW, Trucco E, MacGillivray T, Fekrat S. Multimodal retinal imaging Parkinson’s disease. ARVO 2019, Vancouver.
Pead E, Grewal DS, Yoon SP, Polascik BW, Thompson AC, Burke JR, Dunn C, Trucco E, MacGillivray T, Fekrat S. Pilot study of ultra-widefield imaging to study the retinal vasculature in mild cognitive impairment and Alzheimer’s disease. ARVO 2019, Vancouver.
Wisely CE, Grewal DS, Fekrat S. Deep learning algorithm for diagnosis of Alzheimer’s disease using multimodal retinal imaging. Residents’ and Fellows’ Day, Duke Eye Center, 2019.
Bhullar P, Grewal S, Fekrat S. Evaluation of potential biomarkers in multimodal retinal images for diagnosis of Parkinson’s disease: pilot study. Residents’ and Fellows’ Day, Duke Eye Center, 2019.
Cai S, Gray CD, Robbins C, Thompson AC, Yoon SP, Polascik BW, Hamid C, MacGillivray T, Fekrat S, Grewal DS. Optical coherence tomography angiography fractal dimension in Alzheimer’s disease, mild cognitive impairment, and age-matched cognitively healthy controls. ARVO, Baltimore, 2020 (cancelled due to COVID-19).
Robbins C, Grewal DS, Thompson AC, Yoon SP, Plassman B, Fekrat S. Repeatability, interocular symmetry, and correlation with age of peripapillary optical coherence tomography angiography parameters in healthy eyes. ARVO, Baltimore, 2020 (cancelled due to COVID-19).
Robbins CB, Grewal DS, Powers JH, Thompson AC, Polascik BW, Agrawal R, Fekrat S. Subfoveal choroidal thickness and choroidal vascularity index on spectral-domain optical coherence tomography in Alzheimer’s disease. Alzheimer’s Association International Conference, Amsterdam, 2020 (cancelled due to COVID-19).
Robbins CB, Grewal DS, Bhullar PK, Thompson AC, Yoon SP, Polascik BW, Agrawal R, Fekrat S. Characterization of retinal microvascular and structural changes in Parkinson’s disease using optical coherence tomography angiography. Residents’ and Fellows’ Day, Duke Eye Center, 2020.
Cai S, Gray CD, Robbins C, Thompson AC, Yoon SP, Polascik BW, Hamid C, MacGillivray T, Fekrat S, Grewal DS. Optical coherence tomography angiography fractal dimension in Alzheimer’s disease, mild cognitive impairment, and age-matched cognitively healthy controls. The Retina Society, 2020.
Robbins CB, Grewal DS, Fekrat S. Characterization of retinal microvascular and choroidal structural changes in Parkinson's disease using optical coherence tomography angiography. AAO, 2020.
Robbins CB, Grewal DS, Fekrat S. From eye to brain: correlating retinal and choroidal vascular parameters with volumetric MRI in Alzheimer’s disease and mild cognitive impairment. Duke VisionFest Virtual Symposium 2020.
Mirzania D, Thompson AC, Robbins CB, Grewal DS, Fekrat S. Sex differences in retinal microvasculature and neurodegenerative changes in Alzheimer’s disease: a case-control study. Duke VisionFest Virtual Symposium 2020.
Cai S, Robbins CB, Grewal DS, Fekrat S. OCT angiography multifractal analysis of Alzheimer’s disease, mild cognitive impairment, and healthy controls. Duke VisionFest Virtual Symposium 2020.
Akrobetu D, Robbins CR, Stinnett SS, Soundararajan S, Liu A, Johnson K, Grewal DS, Fekrat S. Assessment of retinal microvascular alterations in individuals with amnestic and non-amnestic mild cognitive impairment using optical coherence tomography angiography. ARVO 2021.
Robbins CR, Grewal DS, Wang D, Wisely CE, Henao R, Lee JM, Agrawal R, Soundararajan S, Thompson AC, Plassman B, Lad E, Whitson H, Carin L, Fekrat S. Analyzing the retinal and choroidal vasculature and structure in cognitively healthy individuals at higher genetic risk for Alzheimer’s disease using a convolutional neural network. ARVO 2021.
Wisely CE, Robbins CR, Ma J, Kim T, Grewal DS, Fekrat S. Correlation of aqueous humor and plasma concentrations of amyloid and tau in older adults without dementia. ARVO, 2021.
Ma J, Robbins CB, Pead E, McGrory S, Hamid C, Grewal DS, Scott BL, Trucco E, MacGillivray T, Fekrat S. Retinal vascular changes in Parkinson’s disease on ultra-widefield retinal imaging. ARVO 2021.
Robbins CB, Grewal DS, Soundararajan S, Stinnett S, Liu A, Johnson KG, Fekrat S. Radial peripapillary capillary network microvascular changes in Alzheimer’s disease, mild cognitive impairment, and cognitively healthy controls. Alzheimer’s Association International Conference 2021.
Mirzania D, Robbins CB, Thompson AC, Yoon SP, Liu A, Johnson KG, Grewal DS, Fekrat S. Retinal microvasculature and neurodegenerative changes in males vs females with Alzheimer’s disease: a case-control study. Alzheimer’s Association International Conference 2021.
Akrobetu D, Robbins CB, Stinnett SS, Soundararajan S, Liu A, Johnson KG, Grewal DS, Fekrat S. Assessment of retinal microvascular alterations in individuals with amnestic and non-amnestic mild cognitive impairment using optical coherence tomography angiography. Alzheimer’s Association International Conference 2021.
Rashid D, Bernabeu Llinares M, Cai S, Giarratano Y, Gray C, Hamid C, Grewal DS, Robbins CB, Soundararajan S, Ma J, Fekrat S, MacGillivray TJ. Reproducibility of retinal vascular phenotypes obtained with optical coherence tomography angiography: importance of vessel segmentation. Medical Image Understanding and Analysis (MIUA) conference 2021.
Mirzania D, Robbins CB, Thompson AC, Yoon SP, Liu A, Johnson KG, Grewal DS, Fekrat S. Retinal and choroidal changes in males compared to females with Alzheimer’s disease: a case-control study. Women in Ophthalmology, 2021.
Mirzania D, Robbins CB, Thompson AC, Yoon SP, Liu A, Johnson KG, Grewal DS, Fekrat S. Retinal and choroidal changes in males compared to females with Alzheimer’s disease: a case-control study. ASRS, San Antonio, 2021.
Robbins CB, Wong D, Grewal DS, Wisely CE, Henao R, Soundararajan S, Ma J, Plassman B, Lad E, Whitson H, Carin L, Fekrat S. A convolutional neural network to identify cognitively healthy individuals at higher genetic risk for Alzheimer’s disease. ASRS, San Antonio, 2021.
Ma J, Robbins CB, Pead E, McGrory S, Hamid C, Grewal DS, Scott BL, Trucco E, MacGillivray T, Fekrat S. Investigating retinal vascular changes in Parkinson’s disease using ultra-widefield retinal imaging. ASRS, San Antonio, 2021.
Akrobetu D, Robbins CB, Stinnett SS, Soundararajan S, Liu AJ, Johnson KG, Grewal DS, Fekrat S. Assessment of retinal microvascular alterations in individuals with amnestic and non-amnestic mild cognitive impairment using OCT angiography. ASRS, San Antonio, 2021.
Robbins CB, Wisely CE, Singh P, Kim T, Grewal DS, Fekrat S. Quantifying neuronal biomarkers in aqueous humor in individuals undergoing routine cataract surgery and correlating with age and cognition. ASCRS, 2022.
Akrobetu D, Robbins CB, Grewal DS, Fekrat S. Intrasession repeatability of macular optical coherence tomography angiography parameters in neurodegenerative disease. ARVO, 2022.
Kundu A, Ma J, Robbins CB, Pant P, Soundararajan S, Stinnett S, Scott B, Moore K, Grewal DS, Fekrat S. Multimodal retinal imaging in Parkinson’s disease: A longitudinal analysis. ARVO, 2022.
Kundu A, Ma J, Robbins CB, Pant P, Soundararajan S, Stinnett S, Scott B, Moore K, Grewal DS, Fekrat S. Differences in rate of change of retinal structural and microvasculature parameters in Parkinson’s disease compared to controls. ASRS, 2022.
Kundu A, Ma J, Robbins CB, Pant P, Soundararajan S, Stinnett S, Scott B, Moore K, Grewal DS, Fekrat S. Differences in rate of change of retinal structural and microvasculature parameters in Parkinson’s disease compared to controls. Alzheimer’s Association International Conference (AAIC), 2022.
Kundu A, Ma J, Robbins CB, Pant P, Soundararajan S, Stinnett S, Scott B, Moore K, Grewal DS, Fekrat S. Longitudinal Analysis of Retinal Structural and Microvascular Parameters in Parkinson’s Disease compared to Controls. Women in Ophthalmology (WIO) Summer Symposium, 2022.
Kundu A, Ma J, Robbins CB, Pant P, Soundararajan S, Stinnett S, Scott B, Moore K, Grewal DS, Fekrat S. Differences in rate of change of retinal structural and microvasculature parameters in Parkinson’s disease compared to controls. Duke Ophthalmology Trainee Day, 2022.
Konda SM, Robbins C, Stinnett S, Ma J, Kundu A, Pant P, Mousa H, Agrawal R, Moore K, Grewal DS, Fekrat S. Analysis of retinal and choroidal changes in males and females with Parkinson’s disease using OCT and OCTA. Duke Ophthalmology Trainee Day, 2022.
Justin G, Winslow L, Robbins CB, Pant P, Kundu A, Hsu ST, Boisvert CJ, Tagg NT, Stinnett S, Grewal DS, Fekrat S. Evaluating the retinal architecture and microvasculature in traumatic brain injury using OCTA. Duke Ophthalmology Trainee Day, 2022.
Justin GA, Winslow L, Robbins CB, Pant P, Kundu A, Hsu ST, Boisvert CJ, Tagg NT, Stinnett SS, Grewal DS, Fekrat S. Evaluating the retinal architecture and microvasculature in traumatic brain injury using optical coherence tomography angiography. The Retina Society, Pasadena, 2022.
Winslow L, Justin GA, Robbins CB, Pant P, Kundu A, Hsu ST, Boisvert C, Tagg NT, Stinnett SS, Grewal DS, Fekrat S. Evaluating the retinal structure and microvasculature in traumatic brain injury and concussion using multimodal retinal imaging. NCSEPS, Greensboro, 2022.
Kundu A, Ma JP, Robbins CB, Pant P, Soundararajan S, Stinnett SS, Scott BL, Moore KP, Grewal DS, Fekrat S. Longitudinal analysis of retinal structural and microvasculature parameters in Parkinson disease compared to controls. NCSEPS, Greensboro, 2022.
Media Coverage:
2017 Duke study suggests earliest sign of Alzheimer’s could be linked to eye problems. www.wral.com
Duke Health issued a press release on March 5, 2019 that received overwhelming coverage including the following:
2019 New study shows an eye scan can detect signs of Alzheimer’s disease. www.eurekalert.org
2019 ENC Health Currents: Could Alzheimer’s be diagnosed with an eye exam? www.publicradioeast.org
2019 New study shows an eye scan can detect signs of Alzheimer’s disease. www.eyewire.news
2019 Eye scan can detect signs of Alzheimer’s disease. www.physicsworld.com
2019 Eye exam could soon detect Alzheimer’s, new study suggests. www.foxnews.com
2019 2 studies use retinal scans to find early Alzheimer’s disease. www.fiercebiotech.com
2019 Alzheimer’s disease can be spotted through simple eye test. www.telegraph.co.uk
2019 Alzheimer’s disease could one day be diagnosed with an eye test. www.newsweek.com
2019 Eye exams may someday detect Alzheimer’s disease. www.aarp.com
2019 Routine eye exam could one day diagnose Alzheimer’s before symptoms show, Duke doctors say. www.abc11.com
2019 Could an eye doctor diagnose Alzheimer’s before you have symptoms? www.sciencedaily.com
2019 Could an eye test help detect Alzheimer’s disease? www.cbsnews.com
Duke Health issued a press release on November 30, 2020 - AI Model Uses Retinal Scans to Predict Alzheimer's Disease
2020 AI model uses retinal scans to predict Alzheimer’s disease. www.sciencedaily.com
2021 Eye changes may identify Parkinson’s disease. www.medscape.com
2021 Our eyes may provide early warning signs of Alzheimer’s and Parkinson’s www.washingtonpost.com
2021 Eyes show early warning signs for Alzheimer’s. www.iol.co.za